Research and Development
5 Reasons Why Diversity Matters in Clinical Trials
Broadening access to clinical trials is better for science and patients.
Research Aimed at the Sickest COVID-19 Patients
Dr. William Zhang receives the American Thoracic Society/CSL Behring Research Award to study Acute Respiratory Distress Syndr…
Together, Let's Move at the Speed of Science
A condensed version of my address to academia, governments and industry during the Times Higher Education Health and Wellbein…
Listen: The Safety of Vaccines
Gregg Sylvester, Chief Medical Officer and Head of Medical Affairs for Seqirus, discusses vaccine safety on new episode of Wo…
Biotech Firms Respond to IP Debate
Hundreds of CEOs sign a joint statement, saying IP “created the biotech network that responded so quickly to the COVID crisis…
Listen: How Technology Is Changing Vaccines
On a new episode of World of Promise, an R&D leader discusses vaccine innovation, including aQIVc and self-amplifying mRNA.
Video: Bringing the Patient Perspective to Work
One CSL Behring employee’s experience as a clinical trial participant now informs her work to help fellow patients.
"Flu Will Return, Make No Doubt About It"
See what Beverly Taylor, a leader at one of the world’s largest flu vaccine providers, Seqirus, said about the upcoming flu s…
A Reckoning With Pain
Sickle cell patient and community advocate, Kyle Smith, describes the physical and emotional impact of a disease too long in …
CSL Behring's New R&D Campus in Germany
Video: “Topping-out” milestone celebrated in Marburg for facility scheduled to open in 2022.